Briones GJC, Flores CY, Anaya HJ, Díaz LPM, Sevilla CAE, Briones VCG

Language: Spanish
References: 22
Page: s14-19
PDF size: 88.81 Kb.

REFERENCES

1. Thornton C, Dahlen H, Korda A, Hennessy A. The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000-2008. Am J Obstet Gynecol. 2013; 208 (6): 476.e1-476.e5.

2. Scazzocchio E, Figueras F. Contemporary prediction of preeclampsia. Curr Opin Obstet Gynecol. 2011; 23 (2): 65-71.

3. Manfredi M, Beltramello A, Bongiovanni LG, Polo A, Pistoia L, Rizzuto N. Eclamptic encephalopathy: imaging and pathogenetic considerations. Acta Neurol Scand. 1997; 96 (5): 277-282.

4. Schwartz RB, Feske SK, Polak JF, DeGirolami U, Iaia A, Beckner KM et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology. 2000; 217 (2): 371-376.

5. Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol. 2007; 2 (3): 543-549.

6. Demirtas O, Gelal F, Vidinli BD, Demirtas LO, Uluc E, Baloglu A. Cranial MR imaging with clinical correlation in preeclampsia and eclampsia. Diagn Interv Radiol. 2005; 11 (4): 189-194.

7. Salha O, Walker JJ. Modern management of eclampsia. Postgrad Med J. 1999; 75 (880): 78-82.

8. Brewer J, Owens MY, Wallace K, Reeves AA, Morris R, Khan M et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol. 2013; 208 (6): 468.e1-6.

9. Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D. Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology. 2009; 51 (6): 373-383.

10. Wallace K, Martin JN Jr, Tam Tam K, Wallukat G, Dechend R, Lamarca B et al. Seeking the mechanism(s) of action for corticosteroids in HELLP syndrome: SMASH study. Am J Obstet Gynecol. 2013; 208 (5): 380.e1-8.

11. Bebawy JF. Perioperative steroids for peritumoral intracranial edema: a review of mechanisms, efficacy, and side effects. J Neurosurg Anesthesiol. 2012; 24 (3): 173-177.

12. Dahmus MA, Barton JR, Sibai BM. Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography. Am J Obstet Gynecol. 1992; 167 (4 Pt 1): 935-941.

13. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 1990; 163 (5 Pt 1): 1691-1712.

14. Walker JJ. Hypertensive drugs in pregnancy. Antihypertension therapy in pregnancy, preeclampsia, and eclampsia. Clin Perinatol. 1991; 18 (4): 845-873.

15. Lubbe WF. Hypertension in pregnancy: whom and how to treat. Br J Clin Pharmacol. 1987; 24 Suppl 1 (Suppl 1): 15S-20S.

16. Schiff E, Friedman SA, Sibai BM. Conservative management of severe preeclampsia remote from term. Obstet Gynecol. 1994; 84 (4): 626-630.

17. Brown MA, Zammit VC, Lowe SA. Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension. Clin Sci (Lond). 1989; 77 (6): 599-604.

18. Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ. 1994; 309 (6966): 1395-1400.

19. Royal College of Obstetricians and Gynaecologists (RCOG) Guidelines No 10: Management of eclampsia. London: RCOG; 1996.

20. Keiser SD, Owens MY, Parrish MR, Cushman JL, Bufkin L, May WL et al. HELLP syndrome with and without eclampsia. Am J Perinatol. 2011; 28 (3): 187-194.

21. Kotsarini C, Griffiths PD, Wilkinson ID, Hoggard N. A systematic review of the literature on the effects of dexamethasone on the brain from in vivo human-based studies: implications for physiological brain imaging of patients with intracranial tumors. Neurosurgery. 2010; 67 (6): 1799-1815; discussion 1815.

22. Tam Tam KB, Keiser SD, Sims S, Brewer J, Owens MY et al. Antepartum eclampsia <34 weeks case series: advisable to postpone delivery to administer corticosteroids for fetal pulmonary benefit? J Perinatol. 2011; 31 (3): 161-165.